RAE LYNN COUCH: Open Payments
NPI 1750310868 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 27 payments from 10 companies in 2025. Trend: 2023 $484 · 2024 $441 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| QOL Medical, LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Medtronic, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: RINVOQ, LINZESS, XIFAXAN, VOWST, Sucraid, OMVOH, ENTYVIO, INTERSTIM.
Industry payments across KY — which companies pay providers there.
